Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - AstraZeneca
 More »

  • Pharma Touting Phase II/III Wins in Run-Up to ASCO
    Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, and ... AstraZeneca, too, will be presenting clinical trial data at ASCO, specifically from a ...
    5-16-2013
  • Biotechs Need to Walk the Walk on Drug Value
    ... academic and research institutions. Two months later, 10 pharma giants-AbbVie, AstraZeneca (AZ), Boehringer Ingelheim, Bristol-Myers Squibb (BMS), GlaxoSmithKline, Johnson & ...
    5-15-2013
  • Layoffs Imminent at Astellas: Two U.S. Labs to Close
    ... Astellas follows other pharma giants that have shrunk their R&D operations in recent years-a category that includes AstraZeneca, Roche, Pfizer, and Takeda-as companies scramble to ...
    5-14-2013
  • Companion Diagnostics: 52 Pick-Up
    the deals listed below, for example, Agilent Technologies (which acquired Danish-owned Dako last year) has earlier collaboration agreements with AstraZeneca, Quintiles, and Roche. ...
    5-9-2013
  • Harnessing the Power of Kinase Inhibitors
    ... Other cyclical chemical templates from AstraZeneca, Abbott Laboratories, and Takeda Pharmaceutical mimic the quinolone binding motif, in which they also occupy the unique JNK ...
    5-8-2013
  • AZ Giving Way to Early-Stage Biopharmas in Cheshire
    AstraZeneca has selected the U.K.'s top provider of incubator services, BioCity Nottingham, to establish a new center for early-stage bioscience companies at Alderley Park in ...
    5-7-2013
  • Merck Joins Pfizer to Develop Type 2 Diabetes Drug
    However, not all SGLT2 drugs have overcome regulatory scrutiny. Bristol-Myers Squibb and AstraZeneca won approval in November 2012 from the European Commission for Forxiga, but FDA ...
    4-29-2013
  • Hormone Holds Promise for Replacing Insulin Injections
    ... In addition to CureBeta, Evotec has long-term discovery alliances with partners that include Bayer, Boehringer Ingelheim, CHDI, Genentech, MedImmune/AstraZeneca, and Ono ...
    4-26-2013
  • GEN | Biolinks
    Self-Medication Industry Associazione Delle Impresse del Farmaco Astellas Pharma US AstraZeneca Asuragen Services ATCC ATMI ATR Biotech AusBiotech Australian Academy of Science ...
  • Alchemia, AstraZeneca Partner on $240M Multi-Target Drug Discovery...
    collaboration with AstraZeneca. The companies will work together to discover and potentially develop novel small molecules against multiple AstraZeneca targets using ...
    4-23-2013
  • E&Y: Biotechs Must Walk the Walk on Drug Value
    academic and research institutions. Two months later, 10 pharma giants-AbbVie, AstraZeneca (AZ), Boehringer Ingelheim, Bristol-Myers Squibb (BMS), GlaxoSmithKline, Johnson & ...
    4-22-2013
  • Horizon, AstraZeneca Seek Kinase-Targeting Cancer Drugs
    Horizon Discovery and AstraZeneca are teaming up to explore Horizon's first-in-class ... Find out more about that deal here . Horizon Discovery and AstraZeneca are teaming up to ...
    4-22-2013
  • AstraZeneca, BIND Enter $200M+ Cancer Nanomedicine Agreement
    BIND Therapeutics and AstraZeneca today announced they are working together to develop and ... based on a molecularly targeted kinase inhibitor developed and owned by AstraZeneca. ...
    4-22-2013
  • CEO Perks
    Salary, $1.262 million David Brennan AstraZeneca, CEO and director through June 1, 2012 ... Total 2012 compensation: £3.232 million ($4.973 million) Top three elements: AstraZeneca ...
    4-12-2013
  • AstraZeneca Raises S&P Eyebrows
    ... last year, making it AZ's best-selling drug. Agency lowers credit outlook for pharma giant, citing risk of revenue slide despite comeback strategy AstraZeneca Raises S&P Eyebrows
    4-9-2013

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll